Who Owns Parabilis Medicines Stock?
NASDAQ: PBLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 82.42%
- Held by insiders
- 7.03%
- Institutional holders
- 96
- Institutions 82.4%
- Insiders 7.0%
- Public and other 10.6%
Who owns Parabilis Medicines stock?
Institutional investors own about 82.4% of Parabilis Medicines's shares, spread across 96 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 7.03% of PBLS.
The largest institutional holders are RA Capital Management, L.P. (23.73%), FMR, LLC (8.44%) and Arch Venture Management, Llc (5.26%). Together, the top 10 institutions control 61.2% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their PBLS positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PBLS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| RA Capital Management, L.P. | 28.93M | 23.73% | +100.0% |
| FMR, LLC | 10.29M | 8.44% | +100.0% |
| Arch Venture Management, Llc | 6.41M | 5.26% | +100.0% |
| venBio Partners LLC | 5.27M | 4.32% | +100.0% |
| Alphabet Inc. | 4.92M | 4.03% | +100.0% |
| Nextech Invest, Ltd. | 4.66M | 3.82% | +100.0% |
| Cormorant Asset Management, LP | 4.62M | 3.78% | +100.0% |
| Regeneron Pharmaceuticals Inc | 4.17M | 3.42% | +100.0% |
| Siren, L.L.C. | 2.99M | 2.45% | +100.0% |
| Farallon Capital Management LLC | 2.37M | 1.94% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PBLS
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.12M | 0.92% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 807.76K | 0.66% |
| T. Rowe Price Health Sciences Fund, Inc. | 486.67K | 0.40% |
| JPMorgan Trust II-JPMorgan Small Cap Growth Fund | 480.21K | 0.39% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 478.76K | 0.39% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 436.41K | 0.36% |
| AB CAP FUND, INC.-AB Small Cap Growth Portfolio | 324.26K | 0.27% |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 313.25K | 0.26% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 255.69K | 0.21% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 239.76K | 0.20% |
Frequently asked questions
Who is the largest shareholder of Parabilis Medicines?
RA Capital Management, L.P. is the largest institutional shareholder of PBLS, owning 23.73% of shares outstanding (28.93M shares) as of its latest 13F filing.
What percentage of Parabilis Medicines is owned by institutions?
Institutions own about 82.4% of PBLS shares and 88.6% of the public float.
How much of Parabilis Medicines do insiders own?
Insiders, such as officers and directors, own about 7.03% of PBLS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.